Trial NCT04380545

View at ClinicalTrials.gov 
Org. Study IDs: 2019-1135
Secondary IDs: 2019-1135 NCI-2020-02614

Last trial update was posted on 2024-02-02

MeSH Interventions

Fluorouracil Interferon alpha-2 Interferon-alpha Interferons Nivolumab

MeSH Conditions

Carcinoma Carcinoma, Hepatocellular

Other Conditions

Stage III Hepatocellular Carcinoma AJCC v8 Stage IIIA Hepatocellular Carcinoma AJCC v8 Stage IIIB Hepatocellular Carcinoma AJCC v8 Stage IV Hepatocellular Carcinoma AJCC v8 Stage IVA Hepatocellular Carcinoma AJCC v8 Stage IVB Hepatocellular Carcinoma AJCC v8 Unresectable Fibrolamellar Carcinoma

Stopping Reasons

PI Request

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID